Cargando…

Chyluria: what does the clinician need to know?

Chyluria is secondary to the presence of chyle in the urine. The classical appearance on inspection is of milky white urine, which is caused by a fistulous communication between the lymphatic system and the urinary tract. Worldwide, it is most commonly associated with the parasite Wuchereria bancrof...

Descripción completa

Detalles Bibliográficos
Autores principales: Stainer, Victoria, Jones, Patrick, Juliebø, Siri Øvereng, Beck, Rupert, Hawary, Amr
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366404/
https://www.ncbi.nlm.nih.gov/pubmed/32728391
http://dx.doi.org/10.1177/1756287220940899
_version_ 1783560213500002304
author Stainer, Victoria
Jones, Patrick
Juliebø, Siri Øvereng
Beck, Rupert
Hawary, Amr
author_facet Stainer, Victoria
Jones, Patrick
Juliebø, Siri Øvereng
Beck, Rupert
Hawary, Amr
author_sort Stainer, Victoria
collection PubMed
description Chyluria is secondary to the presence of chyle in the urine. The classical appearance on inspection is of milky white urine, which is caused by a fistulous communication between the lymphatic system and the urinary tract. Worldwide, it is most commonly associated with the parasite Wuchereria bancrofti, which is prevalent in Asia, most extensively in India but also China and Taiwan. However, in the United Kingdom, Europe and North America, where the condition is rare, non-parasitic aetiologies predominate. Chyluria is occasionally associated with other urinary tract symptoms including infection, loin pain and haematuria. It may also cause hypoproteinaemia, weight loss and cachexia. Management is based on identifying the aetiology and depends on the severity of the chyluria and presence of associated symptoms. Given its predominate symptom being urinary, cases in the West can fall under the care of the urologist. The aim of this article is to provide an overview and summary of the aetiology, assessment and management of chyluria based on the most up-to-date evidence available. This was achieved through a non-systematic review of world literature.
format Online
Article
Text
id pubmed-7366404
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-73664042020-07-28 Chyluria: what does the clinician need to know? Stainer, Victoria Jones, Patrick Juliebø, Siri Øvereng Beck, Rupert Hawary, Amr Ther Adv Urol Review Chyluria is secondary to the presence of chyle in the urine. The classical appearance on inspection is of milky white urine, which is caused by a fistulous communication between the lymphatic system and the urinary tract. Worldwide, it is most commonly associated with the parasite Wuchereria bancrofti, which is prevalent in Asia, most extensively in India but also China and Taiwan. However, in the United Kingdom, Europe and North America, where the condition is rare, non-parasitic aetiologies predominate. Chyluria is occasionally associated with other urinary tract symptoms including infection, loin pain and haematuria. It may also cause hypoproteinaemia, weight loss and cachexia. Management is based on identifying the aetiology and depends on the severity of the chyluria and presence of associated symptoms. Given its predominate symptom being urinary, cases in the West can fall under the care of the urologist. The aim of this article is to provide an overview and summary of the aetiology, assessment and management of chyluria based on the most up-to-date evidence available. This was achieved through a non-systematic review of world literature. SAGE Publications 2020-07-16 /pmc/articles/PMC7366404/ /pubmed/32728391 http://dx.doi.org/10.1177/1756287220940899 Text en © The Author(s), 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Review
Stainer, Victoria
Jones, Patrick
Juliebø, Siri Øvereng
Beck, Rupert
Hawary, Amr
Chyluria: what does the clinician need to know?
title Chyluria: what does the clinician need to know?
title_full Chyluria: what does the clinician need to know?
title_fullStr Chyluria: what does the clinician need to know?
title_full_unstemmed Chyluria: what does the clinician need to know?
title_short Chyluria: what does the clinician need to know?
title_sort chyluria: what does the clinician need to know?
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7366404/
https://www.ncbi.nlm.nih.gov/pubmed/32728391
http://dx.doi.org/10.1177/1756287220940899
work_keys_str_mv AT stainervictoria chyluriawhatdoestheclinicianneedtoknow
AT jonespatrick chyluriawhatdoestheclinicianneedtoknow
AT juliebøsiriøvereng chyluriawhatdoestheclinicianneedtoknow
AT beckrupert chyluriawhatdoestheclinicianneedtoknow
AT hawaryamr chyluriawhatdoestheclinicianneedtoknow